David L Braff
Overview
Explore the profile of David L Braff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
5293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bigdeli T, Chatzinakos C, Bendl J, Barr P, Venkatesh S, Gorman B, et al.
medRxiv
. 2024 Sep;
PMID: 39252912
Large-scale genome-wide association studies of schizophrenia have uncovered hundreds of associated loci but with extremely limited representation of African diaspora populations. We surveyed electronic health records of 200,000 individuals of...
2.
Machiraju S, Wyss J, Light G, Braff D, Cadenhead K
Schizophr Res
. 2024 Jul;
271:71-80.
PMID: 39013347
Background: Despite findings from translational and genetic studies in the event-related potential (ERP) literature, the validity and reliability of P50 suppression as a schizophrenia spectrum endophenotype has been questioned. Here,...
3.
Abplanalp S, Braff D, Light G, Joshi Y, Nuechterlein K, Green M
Psychol Med
. 2024 Jan;
54(9):1930-1939.
PMID: 38287656
Background: Research using latent variable models demonstrates that pre-attentive measures of early auditory processing (EAP) and cognition may initiate a cascading effect on daily functioning in schizophrenia. However, such models...
4.
Docherty A, Mullins N, Ashley-Koch A, Qin X, Coleman J, Shabalin A, et al.
Am J Psychiatry
. 2023 Oct;
180(10):723-738.
PMID: 37777856
Objective: Suicidal behavior is heritable and is a major cause of death worldwide. Two large-scale genome-wide association studies (GWASs) recently discovered and cross-validated genome-wide significant (GWS) loci for suicide attempt...
5.
Joshi Y, Molina J, Braff D, Green M, Gur R, Gur R, et al.
Am J Psychiatry
. 2023 Apr;
180(7):519-523.
PMID: 37038743
No abstract available.
6.
Braff D, Bigdeli T
JAMA Psychiatry
. 2022 Aug;
79(10):946-948.
PMID: 35976678
No abstract available.
7.
Abplanalp S, Braff D, Light G, Nuechterlein K, Green M
JAMA Psychiatry
. 2022 Aug;
79(10):1014-1022.
PMID: 35976655
Importance: Improved understanding of the boundaries and connections between positive symptoms, negative symptoms, and role functioning in schizophrenia is critical, given limited empirical support for clear distinctions among these clinical...
8.
Mullins N, Kang J, Campos A, Coleman J, Edwards A, Galfalvy H, et al.
Biol Psychiatry
. 2021 Dec;
91(3):313-327.
PMID: 34861974
Background: Suicide is a leading cause of death worldwide, and nonfatal suicide attempts, which occur far more frequently, are a major source of disability and social and economic burden. Both...
9.
Joshi Y, Thomas M, Braff D, Green M, Gur R, Gur R, et al.
Am J Psychiatry
. 2021 May;
178(9):838-847.
PMID: 33985348
Objective: Many psychotropic medications used to treat schizophrenia have significant anticholinergic properties, which are linked to cognitive impairment and dementia risk in healthy subjects. Clarifying the impact of cognitive impairment...
10.
Koshiyama D, Miyakoshi M, Tanaka-Koshiyama K, Joshi Y, Sprock J, Braff D, et al.
Schizophr Res
. 2021 Mar;
231:73-81.
PMID: 33780847
Background: Schizophrenia patients have abnormal electroencephalographic (EEG) power over multiple frequency bands, even at rest, though the primary neural generators and spatiotemporal dynamics of these abnormalities are largely unknown. Disturbances...